Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Quipt Home Medical (QIPT) Liabilities and Shareholders Equity (2020 - 2025)

Historic Liabilities and Shareholders Equity for Quipt Home Medical (QIPT) over the last 6 years, with Q4 2025 value amounting to $280.7 million.

  • Quipt Home Medical's Liabilities and Shareholders Equity rose 1558.42% to $280.7 million in Q4 2025 from the same period last year, while for Dec 2025 it was $1.0 billion, marking a year-over-year increase of 568.77%. This contributed to the annual value of $283.3 million for FY2025, which is 1457.69% up from last year.
  • As of Q4 2025, Quipt Home Medical's Liabilities and Shareholders Equity stood at $280.7 million, which was up 1558.42% from $283.3 million recorded in Q3 2025.
  • Quipt Home Medical's 5-year Liabilities and Shareholders Equity high stood at $283.3 million for Q3 2025, and its period low was $78.0 million during Q2 2022.
  • Moreover, its 5-year median value for Liabilities and Shareholders Equity was $239.2 million (2023), whereas its average is $191.9 million.
  • As far as peak fluctuations go, Quipt Home Medical's Liabilities and Shareholders Equity plummeted by 1040.63% in 2022, and later soared by 21067.03% in 2023.
  • Over the past 5 years, Quipt Home Medical's Liabilities and Shareholders Equity (Quarter) stood at $107.4 million in 2021, then rose by 22.68% to $131.7 million in 2022, then skyrocketed by 85.15% to $243.9 million in 2023, then decreased by 0.44% to $242.8 million in 2024, then grew by 15.58% to $280.7 million in 2025.
  • Its Liabilities and Shareholders Equity stands at $280.7 million for Q4 2025, versus $283.3 million for Q3 2025 and $236.1 million for Q2 2025.